Danaher (NYSE:DHR) issued its earnings results on Thursday. The conglomerate reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.03, MarketWatch Earnings reports. Danaher had a net margin of 13.84% and a return on equity of 11.55%. The firm had revenue of $4.85 billion for the quarter, compared to analysts’ expectations of $4.80 billion. During the same quarter last year, the business earned $1.00 earnings per share. The business’s revenue was up 7.2% on a year-over-year basis.
Shares of Danaher stock opened at $104.96 on Thursday. The company has a quick ratio of 1.07, a current ratio of 1.50 and a debt-to-equity ratio of 0.41. The firm has a market cap of $76.04 billion, a price-to-earnings ratio of 26.04, a PEG ratio of 2.08 and a beta of 1.01. Danaher has a 12 month low of $85.10 and a 12 month high of $110.13.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 26th. Shareholders of record on Friday, September 28th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.61%. The ex-dividend date is Thursday, September 27th. Danaher’s dividend payout ratio is currently 15.88%.
Several analysts recently weighed in on the stock. Zacks Investment Research cut shares of Danaher from a “hold” rating to a “sell” rating in a report on Monday, July 16th. ValuEngine cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Thursday, June 21st. Royal Bank of Canada lifted their price target on shares of Danaher to $107.00 and gave the company a “positive” rating in a report on Thursday, July 19th. They noted that the move was a valuation call. Morgan Stanley lifted their price target on shares of Danaher from $120.00 to $122.00 and gave the company an “overweight” rating in a report on Friday, July 20th. Finally, Bank of America set a $113.00 price target on shares of Danaher and gave the company a “buy” rating in a report on Thursday, July 19th. One analyst has rated the stock with a hold rating and fifteen have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $111.57.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Further Reading: Float
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.